SINGULAR GENOMICS SYSTEMS IN (OMIC) Stock Analyst Earnings Estimates
NASDAQ:OMIC - Nasdaq - US82933R3084 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 770K | 2.911M 278.05% | 2.935M 0.82% | 10.35M 252.64% | 24.262M 134.42% | ||
| EBITDA YoY % growth | -60.15M -123.69% | -91.06M -51.39% | -97.391M -6.95% | -90.244M 7.34% | -90.353M -0.12% | -89.267M 1.20% | |
| EBIT YoY % growth | -61.28M -122.59% | -93.49M -52.56% | -100.901M -7.93% | -93.304M 7.53% | -93.413M -0.12% | -92.327M 1.16% | |
| Operating Margin | N/A | -12,141.56% | -3,466.20% | -3,179.01% | -902.54% | -380.54% | |
| EPS YoY % growth | N/A | -38.10 29.66% | -39.30 -3.15% | -34.66 11.81% | -32.25 6.96% | -26.95 16.43% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -8.13 15.27% | -8.62 15.50% | -8.78 -2.48% | -8.70 -29.47% | -0.31 96.24% | -0.21 97.51% | -0.23 97.33% | -0.26 97.07% | -0.28 10.00% |
| Revenue Q2Q % growth | 1.208M 11.75% | 1.855M 319.68% | 3.168M 329.85% | 4.724M 1,063.55% | 9.884M 718.21% | 13.148M 608.79% | 14.678M 363.32% | 16.208M 243.10% | 17.738M 79.46% |
| EBITDA Q2Q % growth | -20.4M 6.30% | -15.035M 41.79% | -15.065M 27.28% | -15.555M -4.26% | -15.677M 23.15% | -9.578M 36.30% | -11.036M 26.74% | -12.485M 19.74% | -13.943M 11.06% |
| EBIT Q2Q % growth | -22.555M 10.78% | -22.522M 16.11% | -22.987M -0.80% | -22.854M -26.47% | -18.595M 17.56% | -12.495M 44.52% | -13.954M 39.30% | -15.402M 32.61% | -16.861M 9.33% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -6.72 27.74% | -8.21 | 1.49 | 18.16% |
| Q2 2024 Q2Q % growth | -8.57 18.38% | -9.04 | 0.47 | 5.17% |
| Q1 2024 Q2Q % growth | -10.20 -3.03% | -10.71 | 0.51 | 4.76% |
| Q4 2023 Q2Q % growth | -9.60 -10.34% | -10.51 | 0.91 | 8.62% |
| Q3 2023 Q2Q % growth | -9.30 6.06% | -11.63 | 2.33 | 20.02% |
| Q2 2023 Q2Q % growth | -10.50 -2.94% | -11.32 | 0.82 | 7.26% |
| Q1 2023 Q2Q % growth | -9.90 -6.45% | -10.83 | 0.93 | 8.61% |
| Q4 2022 Q2Q % growth | -8.70 -7.41% | -13.04 | 4.34 | 33.26% |
| Q3 2022 Q2Q % growth | -9.90 -32.00% | -12.67 | 2.77 | 21.85% |
| Q2 2022 Q2Q % growth | -10.20 20.93% | -11.75 | 1.55 | 13.19% |
| Q1 2022 Q2Q % growth | -9.30 | -10.20 | 0.90 | 8.82% |
| Q4 2021 Q2Q % growth | -8.10 | -9.42 | 1.32 | 14.06% |
| Q3 2021 Q2Q % growth | -7.50 | -7.34 | -0.16 | -2.12% |
| Q2 2021 Q2Q % growth | -12.90 | -6.22 | -6.68 | -107.33% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 406K -12.12% | 841.5K | -435.5K | -51.75% |
| Q2 2024 Q2Q % growth | 737K 45.94% | 408K | 329K | 80.64% |
| Q1 2024 Q2Q % growth | 442K -48.78% | 401.88K | 40.12K | 9.98% |
| Q4 2023 Q2Q % growth | 1.081M 40.39% | 745.957K | 335.043K | 44.91% |
| Q3 2023 Q2Q % growth | 462K | 1.3M | -838K | -64.46% |
| Q2 2023 Q2Q % growth | 505K | 1.174M | -669K | -56.98% |
| Q1 2023 Q2Q % growth | 863K | 1.267M | -404K | -31.89% |
| Q4 2022 Q2Q % growth | 770K | 774.996K | -4.996K | -0.64% |
| Q3 2022 Q2Q % growth | 76.5K | -76.5K | -100.00% | |
| Q2 2022 Q2Q % growth | 51K | -51K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -2748.21% | 0.83% | 2.37% |
| Revenue | 0% | 37.31% | 0% | -8.68% |